Key result
Passenger CD4 T cells within heart transplants contribute to allograft vasculopathy by providing help to recipient B cells for autoantibody generation.
Why the study?
Do donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production in a mouse model?
Do donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production in a mouse model?
Passenger CD4 T cells within heart transplants contribute to allograft vasculopathy by helping recipient B cells generate autoantibodies.
Answers are grounded in this paper and cite their sources.
Should not alter clinical transplant management; animal data leaves open passenger CD4 T-cell targeting for human allograft vasculopathy.
BACKGROUND: The development of autoantibody after heart transplantation is increasingly associated with poor graft outcome, but what triggers its development and whether it has a direct causative role in graft rejection is not clear. Here, we study the development of antinuclear autoantibody in an established mouse model of heart allograft vasculopathy. METHODS AND RESULTS: Humoral vascular changes, including endothelial complement staining, were present in bm12 heart grafts, explanted 50 days after transplantation. Alloantibody was not detectable, but long-lasting autoantibody responses developed in C57BL/6 recipients from the third week after transplantation. No autoantibody was generated if donor CD4 T cells were depleted before heart graft retrieval or in recipients that lacked B-cell major histocompatibility complex class II expression, indicating that humoral autoimmunity is a consequence of donor CD4 T-cell allorecognition of the major histocompatibility complex class II complex on recipient autoreactive B cells. An effector role for autoantibody in graft rejection was confirmed by abrogation of humoral vascular rejection, and attenuation of vasculopathy, in B-cell deficient recipients and by development of vascular obliteration and accelerated rejection in recipients primed for autoantibody before transplantation. CONCLUSIONS: Passenger CD4 T cells within heart transplants can contribute to allograft vasculopathy by providing help to recipient B cells for autoantibody generation.
No takes yet. Share an insight, caveat, or question.
Win et al. (2009) studied Heart allograft vasculopathy. Donor CD4 T cells vs. Depletion of donor CD4 T cells or B-cell deficient recipients was evaluated on Development of antinuclear autoantibody and humoral vascular changes. Passenger CD4 T cells within heart transplants contribute to allograft vasculopathy by providing help to recipient B cells for autoantibody generation.
Synapse has enriched 10 related papers. Consider them for comparative context: